OR WAIT 15 SECS
The AACE and Takeda Pharmaceuticals North America Inc. have partnered to launch the Diabetes Navigator, a collection of type 2 diabetes information available online for patients and caregivers.
The American Association of Clinical Endocrinologists (AACE) and Takeda Pharmaceuticals North America Inc. have partnered to launch the Diabetes Navigator, a collection of type 2 diabetes information available online for patients and caregivers.
The new compendium, created and reviewed by leading clinical endocrinologists, was created to help healthcare professionals provide patients with guidance in navigating the abundance of diabetes information available online.
“It is important for patients and caregivers to access educational resources they can trust; unfortunately, not all diabetes information online is useful or reliable,” said George Grunberger, MD, AACE board member and founder and chair of the Grunberger Diabetes Institute, Bloomfield Hills, Mich. “The Diabetes Navigator assembles selected information that experts themselves use and refer to, which can serve as a basis for a well-informed disease management discussion among patients, caregivers, and healthcare professionals.”
The Diabetes Navigator is a patient-friendly, easy-to-navigate website, divided into 3 categories: disease management, lifestyle, and tools. Using the compendium, visitors can identify and access reputable websites offering key information about type 2 diabetes, how to work with a healthcare team, and how to maintain a healthy lifestyle. The Diabetes Navigator includes facts and figures, tips, and trackers designed to help patients manage the disease, and it provides guidance on how to search for reliable information online. A list of reputable professional organizations and patient websites is included.
Content presented in the Diabetes Navigator was created and reviewed by Grunberger and the following endocrinologists:
• Yehuda Handelsman, MD, AACE president, medical director, and principal investigator, Metabolic Institute of America
• Lawrence Blonde, MD, AACE board member, director of the Ochsner Diabetes Clinical Research Unit, New Orleans, La.
• Philip Levy, MD, AACE board member and chair of the Endocrinology and Metabolism Section at Banner Good Samaritan Regional Medical Center, Phoenix, Ariz.